Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JOHN MUIR HEALTH

NPI: 1740215219 · WALNUT CREEK, CA 94598 · General Acute Care Hospital · NPI assigned 07/12/2006

$32.37M
Total Medicaid Paid
549,527
Total Claims
454,004
Beneficiaries
260
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKNIGHT, CALVIN (PRESIDENT AND CHIEF EXECUTIVE OFFIC)
NPI Enumeration Date07/12/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 67,136 $5.22M
2019 63,817 $3.15M
2020 51,284 $2.55M
2021 71,778 $3.51M
2022 86,442 $5.24M
2023 99,075 $5.72M
2024 109,995 $6.98M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J3490 Unclassified drugs 71,856 30,515 $13.34M
0450 Emergency room services 59,037 53,326 $2.30M
0121 245 235 $2.01M
82803 1,141 1,110 $1.38M
0202U Oncology (prostate), multianalyte, gene expression profiling 3,668 3,626 $1.07M
74177 Computed tomography, abdomen and pelvis; with contrast material 3,824 3,753 $710K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 10,650 9,875 $600K
0272 5,549 5,365 $565K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,821 2,665 $426K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 5,473 5,282 $376K
0123 57 51 $359K
78815 Positron emission tomography (PET) for limited area imaging 268 267 $348K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,710 2,625 $341K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 15,855 14,812 $310K
70450 Computed tomography, head or brain; without contrast material 3,849 3,771 $303K
80053 Comprehensive metabolic panel 25,822 23,807 $273K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6,181 6,002 $264K
J7030 Infusion, normal saline solution , 1000 cc 11,413 9,565 $221K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,485 4,359 $209K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 30,462 27,056 $209K
96361 Intravenous infusion, hydration; each additional hour 8,693 7,685 $207K
96376 2,697 1,768 $199K
96375 Therapeutic injection; each additional sequential IV push 7,008 6,103 $196K
0250 2,008 1,343 $192K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,221 3,020 $188K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,576 1,555 $164K
99199 Unlisted special service, procedure or report 3,186 2,834 $162K
72125 Computed tomography, cervical spine; without contrast material 1,417 1,406 $151K
93976 871 855 $151K
76705 Ultrasound, abdominal, real time with image documentation; limited 3,274 3,206 $148K
71045 Radiologic examination, chest; single view 10,110 9,772 $148K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 6,632 5,010 $147K
0171 Inj, epinephrine (belcher) 108 105 $145K
71046 Radiologic examination, chest; 2 views 6,662 6,562 $140K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,543 1,496 $134K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,080 1,077 $130K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 2,428 2,395 $125K
99283 Emergency department visit for the evaluation and management, moderate severity 1,662 1,447 $125K
77067 Screening mammography, bilateral, including computer-aided detection 1,397 1,397 $124K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 9,095 3,939 $121K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,549 1,533 $113K
70498 647 644 $109K
76830 Ultrasound, transvaginal 1,906 1,886 $100K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 4,331 2,125 $96K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,202 1,092 $94K
99284 Emergency department visit for the evaluation and management, high severity 2,171 1,977 $91K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,233 1,164 $91K
97530 Therapeutic activities, direct patient contact, each 15 minutes 4,475 2,730 $90K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 363 363 $90K
84484 10,345 8,840 $89K
93971 1,123 1,103 $87K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 6,482 5,970 $84K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,111 995 $81K
71275 Computed tomographic angiography, chest, with contrast material 419 416 $77K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,153 2,131 $74K
70496 332 331 $67K
80048 Basic metabolic panel (calcium, ionized) 5,740 5,075 $67K
99070 1,914 909 $64K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 277 277 $64K
76801 977 855 $63K
83690 9,636 9,052 $60K
76770 1,026 1,015 $59K
76700 Ultrasound, abdominal, real time with image documentation; complete 941 936 $57K
0720 2,228 1,784 $53K
59025 Fetal non-stress test 2,012 1,596 $52K
0122 15 12 $50K
84703 7,964 7,640 $49K
80320 423 399 $48K
81001 16,095 15,272 $48K
76642 952 836 $43K
87086 Culture, bacterial; quantitative colony count, urine 6,180 5,959 $42K
99233 Prolong inpt eval add15 m 976 396 $41K
97161 831 829 $39K
77386 108 12 $38K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 610 545 $38K
74018 2,058 2,016 $35K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,678 5,811 $35K
77066 Tomosynthesis, mammo 384 384 $34K
94664 2,351 2,270 $33K
83880 1,309 1,269 $33K
97139 2,016 550 $33K
84443 Thyroid stimulating hormone (TSH) 2,176 2,117 $32K
Z7502 1,369 1,277 $31K
73564 1,393 1,383 $31K
77063 Screening digital breast tomosynthesis, bilateral 1,353 1,353 $30K
J2270 Injection, morphine sulfate, up to 10 mg 3,525 2,993 $30K
87040 3,402 2,027 $29K
84702 2,307 2,114 $29K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,042 4,718 $29K
0510 1,214 1,126 $28K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 252 68 $28K
73630 1,309 1,300 $26K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" 1,917 995 $25K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 126 126 $24K
83605 3,086 2,763 $23K
J1170 Injection, hydromorphone, up to 4 mg 2,373 1,750 $21K
80306 393 372 $20K
73030 976 970 $20K
77301 26 26 $19K
76536 382 381 $19K
73610 923 920 $18K
77065 Tomosynthesis, mammo 257 257 $18K
82553 349 329 $16K
87077 2,367 1,932 $15K
71250 160 160 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 689 674 $15K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,996 1,736 $15K
72100 643 641 $14K
0002A 359 359 $14K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,041 886 $13K
87186 1,886 1,633 $13K
0001A 323 323 $13K
99232 Subsequent hospital care, per day, moderate complexity 339 185 $12K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 687 673 $11K
85379 1,223 1,200 $11K
77049 32 32 $10K
77336 269 137 $10K
77300 106 102 $10K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 1,626 1,469 $10K
77338 55 53 $10K
85730 1,982 1,917 $10K
J7050 Infusion, normal saline solution, 250 cc 1,830 1,608 $9K
85610 2,885 2,759 $9K
83735 1,558 1,351 $9K
A9585 Injection, gadobutrol, 0.1 ml 360 346 $9K
73130 356 351 $8K
72110 206 206 $8K
86901 3,231 3,151 $7K
97162 156 156 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 230 225 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,302 1,151 $7K
86900 2,921 2,863 $7K
86850 2,448 2,389 $7K
97014 759 327 $7K
80047 1,099 1,080 $7K
85027 1,729 1,633 $7K
J2704 Injection, propofol, 10 mg 345 282 $6K
94729 123 123 $6K
0360 117 63 $6K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 16 16 $6K
J0780 Injection, prochlorperazine, up to 10 mg 426 402 $5K
G0299 Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes 33 26 $5K
70486 52 52 $5K
J2060 Injection, lorazepam, 2 mg 990 863 $5K
77334 49 43 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 988 879 $4K
73110 207 205 $4K
87070 450 443 $4K
87507 12 12 $4K
73502 135 134 $4K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 345 332 $4K
J7120 Ringers lactate infusion, up to 1000 cc 523 433 $4K
82550 712 636 $4K
86140 797 752 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 598 584 $3K
0420 298 292 $3K
0636 304 181 $3K
76377 296 285 $3K
77062 338 338 $3K
Z7610 423 360 $3K
84145 153 138 $3K
J8540 Dexamethasone, oral, 0.25 mg 508 270 $3K
90715 99 99 $3K
72040 126 126 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 794 726 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 170 94 $2K
82150 952 940 $2K
73140 144 142 $2K
0710 237 199 $2K
0762 492 245 $2K
83036 Hemoglobin; glycosylated (A1C) 239 237 $2K
97165 29 29 $2K
97166 25 25 $2K
76870 40 40 $2K
J1815 Injection, insulin, per 5 units 106 49 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg 251 231 $2K
94726 39 39 $1K
85652 655 620 $1K
J1756 Injection, iron sucrose, 1 mg 22 12 $1K
J1650 Injection, enoxaparin sodium, 10 mg 149 66 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 229 225 $1K
73080 57 56 $1K
73590 86 83 $1K
77061 135 135 $1K
J1171 Injection, hydromorphone, 0.1 mg 49 35 $971.21
84439 126 121 $949.82
85049 319 297 $934.37
85014 366 334 $925.90
36430 3,222 1,399 $907.36
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 223 199 $850.42
0370 32 32 $826.88
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 13 12 $823.32
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 122 119 $823.00
94060 26 26 $749.19
77077 25 25 $690.87
87420 166 165 $599.27
85018 330 303 $596.05
72082 14 14 $591.22
0270 278 143 $548.76
88305 Level IV - Surgical pathology, gross and microscopic examination 12 12 $537.31
87581 16 16 $511.97
87486 16 16 $511.97
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 17 17 $488.00
84450 106 105 $463.59
85048 247 246 $447.43
84075 106 105 $434.40
82247 106 105 $430.19
82040 107 106 $427.05
97039 26 12 $415.92
72050 13 13 $413.49
0300 392 375 $408.08
82565 225 219 $387.39
J3480 Injection, potassium chloride, per 2 meq 36 28 $378.85
0301 464 440 $372.65
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 62 62 $364.53
80051 178 178 $349.97
72070 13 13 $327.34
J2250 Injection, midazolam hydrochloride, per 1 mg 65 62 $314.31
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 14 13 $313.12
84155 106 105 $312.33
73560 31 31 $306.79
73620 13 13 $236.34
J0131 Injection, acetaminophen, not otherwise specified,10 mg 14 13 $231.20
81003 112 111 $222.63
J0690 Injection, cefazolin sodium, 500 mg 33 26 $199.96
82947 182 182 $196.96
S0265 Genetic counseling, under physician supervision, each 15 minutes 13 13 $195.00
84520 192 191 $192.40
72170 14 14 $169.44
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 14 12 $164.24
87210 41 40 $153.83
73070 12 12 $117.60
82570 24 24 $110.86
84550 29 27 $105.07
J1644 Injection, heparin sodium, per 1000 units 16 14 $104.70
82330 12 12 $103.68
97035 18 12 $102.01
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 78 73 $92.83
82248 16 12 $70.28
83615 14 14 $64.44
84156 13 12 $42.38
87205 14 13 $38.35
84295 12 12 $30.00
84132 12 12 $29.72
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 150 120 $0.02
0258 98 94 $0.00
0410 99 96 $0.00
0306 276 267 $0.00
0307 158 154 $0.00
0305 404 387 $0.00
0324 157 151 $0.00
0271 104 103 $0.00
0310 25 25 $0.00
80329 28 13 $0.00
0730 166 162 $0.00
0470 93 90 $0.00
0302 135 131 $0.00
0402 77 75 $0.00
0320 84 81 $0.00
0430 12 12 $0.00